https://clinicaltrials.gov/ct2/show/NCT03624920?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F07%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Safety and Efficacy of THN102 in Patients With Parkinson’s Disease and Excessive Daytime Sleepiness
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: THN102 Dosage A; Drug: THN102 Dosage B; Drug: THN102 Dosage C
Sponsor: Theranexus
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03624920
FIRST POSTED:
Fri, 10 Aug 2018 12:00:00 EDT
LAST UPDATE POSTED:
05/21/19 06:55AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03624920?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F07%2F2019&lupd_d=14&sort=nwst